NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma

Immunology and Cell Biology

Volumn 90, Issue 10, 2012, Pages 983-986

  Chow, Melvyn T ^a,b   Tschopp, Jürg ^c   Möller, Andreas ^a,b   Smyth, Mark J ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Asbestos; Cytokine; Inflammasome; Inflammation; Mesothelioma; Skin

Indexed keywords

ASBESTOS; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOCOMPETENT CELL; INFLAMMATION; MALIGNANT MESOTHELIOMA; MOUSE; NONHUMAN; PHENOTYPE; SKIN CANCER;

ANIMALS; ASBESTOS; CARRIER PROTEINS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MESOTHELIOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PAPILLOMA; PERITONEUM; PLEURAL NEOPLASMS; SKIN NEOPLASMS;

MUS;

EID: 84870551811     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.46     Document Type: Article

References (17)

1. Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622.
2. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
3. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
4. Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumour formation. J Immunol 2010; 185: 4912-4920.
5. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB et al. The NLRP3 inflammasome functions as a negative regulator of tumourigenesis during colitisassociated cancer. J Exp Med 2010; 207: 1045-1056.
6. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157: 1666-1680.
7. Selikoff IJ, Churg J, Hammond EC. Classics in oncology: asbestos exposure and neoplasia. CA Cancer J Clin 1984; 34: 48-56.
8. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674-677.
9. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008; 105: 9035-9040.
10. O'Neill LA. Immunology. How frustration leads to inflammation. Science 2008; 320: 619-620.
11. Wang Y, Faux SP, Hallden G, Kirn DH, Houghton CE, Lemoine NR et al. Interleukin- 1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite. Int J Oncol 2004; 25: 173-178.
12. Robinson C, van Bruggen I, Segal A, Dunham M, Sherwood A, Koentgen F et al. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res 2006; 66: 10786-10794.
13. Robinson C, Walsh A, Larma I, O'Halloran S, Nowak AK, Lake RA. MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma. Eur J Cancer 2011; 47: 151-161.
14. Davis M, Manning L, Whitaker D, Garlepp M, Robinson B. Establishment of a murine model of malignant mesothelioma. Int J Cancer 1992; 52: 881-886.
15. Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumourigenesis. Proc Natl Acad Sci USA 2008; 105: 652-656.
16. Beamer CA, Migliaccio CT, Jessop F, Trapkus M, Yuan D, Holian A. Innate immune processes are sufficient for driving silicosis in mice. J Leukoc Biol 2010; 88: 547-557.
17. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241.